Skip to main content

Placebo-controlled randomized study of hydrazine sulfate in lung cancer.

Publication ,  Journal Article
Kosty, MP; Herndon, JE; Green, MR; McIntyre, OR
Published in: J Clin Oncol
June 1995

Duke Scholars

Published In

J Clin Oncol

DOI

ISSN

0732-183X

Publication Date

June 1995

Volume

13

Issue

6

Start / End Page

1529 / 1530

Location

United States

Related Subject Headings

  • Randomized Controlled Trials as Topic
  • Prospective Studies
  • Oncology & Carcinogenesis
  • Lung Neoplasms
  • Hydrazines
  • Humans
  • Double-Blind Method
  • Carcinoma, Non-Small-Cell Lung
  • Antineoplastic Agents
  • 3211 Oncology and carcinogenesis
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Kosty, M. P., Herndon, J. E., Green, M. R., & McIntyre, O. R. (1995). Placebo-controlled randomized study of hydrazine sulfate in lung cancer. J Clin Oncol, 13(6), 1529–1530. https://doi.org/10.1200/JCO.1995.13.6.1529
Kosty, M. P., J. E. Herndon, M. R. Green, and O. R. McIntyre. “Placebo-controlled randomized study of hydrazine sulfate in lung cancer.J Clin Oncol 13, no. 6 (June 1995): 1529–30. https://doi.org/10.1200/JCO.1995.13.6.1529.
Kosty MP, Herndon JE, Green MR, McIntyre OR. Placebo-controlled randomized study of hydrazine sulfate in lung cancer. J Clin Oncol. 1995 Jun;13(6):1529–30.
Kosty, M. P., et al. “Placebo-controlled randomized study of hydrazine sulfate in lung cancer.J Clin Oncol, vol. 13, no. 6, June 1995, pp. 1529–30. Pubmed, doi:10.1200/JCO.1995.13.6.1529.
Kosty MP, Herndon JE, Green MR, McIntyre OR. Placebo-controlled randomized study of hydrazine sulfate in lung cancer. J Clin Oncol. 1995 Jun;13(6):1529–1530.

Published In

J Clin Oncol

DOI

ISSN

0732-183X

Publication Date

June 1995

Volume

13

Issue

6

Start / End Page

1529 / 1530

Location

United States

Related Subject Headings

  • Randomized Controlled Trials as Topic
  • Prospective Studies
  • Oncology & Carcinogenesis
  • Lung Neoplasms
  • Hydrazines
  • Humans
  • Double-Blind Method
  • Carcinoma, Non-Small-Cell Lung
  • Antineoplastic Agents
  • 3211 Oncology and carcinogenesis